LON:GNS - Genus Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 2,300 -16.00 (-0.69 %)
(As of 02/20/2019 03:09 PM ET)
Previous CloseGBX 2,316
Today's RangeGBX 2,294 - GBX 2,336
52-Week RangeGBX 1,652 - GBX 2,597
Volume43,830 shs
Average Volume78,154 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos, which are delivered through artificial insemination to breed dairy and beef cattle with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in vitro fertilization, reproductive, and other technical services to farmers; and agricultural and agri-food consultancy services. Genus plc was incorporated in 1994 and is headquartered in Basingstoke, the United Kingdom.

Receive GNS News and Ratings via Email

Sign-up to receive the latest news and ratings for GNS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone+44-1256-347100

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees2,900
OptionableNot Optionable

Genus (LON:GNS) Frequently Asked Questions

What is Genus' stock symbol?

Genus trades on the London Stock Exchange (LON) under the ticker symbol "GNS."

How often does Genus pay dividends? What is the dividend yield for Genus?

Genus declared a dividend on Thursday, September 6th. Investors of record on Thursday, November 15th will be given a dividend of GBX 17.90 per share on Friday, November 30th. This represents a dividend yield of 0.7%. The ex-dividend date is Thursday, November 15th. This is an increase from Genus's previous dividend of $8.10. The official announcement can be seen at this link. View Genus' Dividend History.

What price target have analysts set for GNS?

5 Wall Street analysts have issued 12-month price objectives for Genus' stock. Their predictions range from GBX 1,800 to GBX 2,650. On average, they anticipate Genus' share price to reach GBX 2,416 in the next year. This suggests a possible upside of 5.0% from the stock's current price. View Analyst Price Targets for Genus.

What is the consensus analysts' recommendation for Genus?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genus in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Genus.

Has Genus been receiving favorable news coverage?

Media headlines about GNS stock have trended somewhat negative on Wednesday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Genus earned a news impact score of -1.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next few days.

Who are some of Genus' key competitors?

Who are Genus' key executives?

Genus' management team includes the folowing people:
  • Mr. Karim Bitar, CEO & Exec. Director (Age 54)
  • Mr. Stephen Wilson, Group Fin. Director & Exec. Director (Age 59)
  • Dr. Jonathan Lightner, Chief of R&D and Scientific Officer
  • Mr. Dan Hartley, Group Gen. Counsel & Company Sec.
  • Ms. Angelle R. Rosata, Group HR Director

How do I buy shares of Genus?

Shares of GNS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Genus' stock price today?

One share of GNS stock can currently be purchased for approximately GBX 2,300.

What is Genus' official website?

The official website for Genus is http://www.genusplc.com/.

How can I contact Genus?

Genus' mailing address is Matrix House, Basing View, BASINGSTOKE, RG21 4DZ, United Kingdom. The company can be reached via phone at +44-1256-347100.


MarketBeat Community Rating for Genus (LON GNS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  274 (Vote Outperform)
Underperform Votes:  252 (Vote Underperform)
Total Votes:  526
MarketBeat's community ratings are surveys of what our community members think about Genus and other stocks. Vote "Outperform" if you believe GNS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel